Yan‐Lai Tang

NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer

Ge Qin, Xin Wang, Shubiao Ye et al. · Nature Communications · 2020 · 176 citations · Full text

Medicine, Molecular Biology, Oncology +15

Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway

Ge Qin, Fei Xu, Tao Qin et al. · Oncotarget · 2015 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice

Yufeng Liu, Michela Perego, Qiang Xiao et al. · Journal of Clinical Investigation · 2019 · 83 citations · Full text

Life Sciences, Immunology, Pathology +14

MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor

Liang Yan-ni, Yan‐Lai Tang, Zhiyong Ke et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2017 · 66 citations

Medicine, Cancer Biology, Oncology +16

Multicenter randomized trial of arsenic trioxide and Realgar‐<i>Indigo naturalis</i> formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study

Minghua Yang, Wuqing Wan, Jie‐Si Luo et al. · American Journal of Hematology · 2018 · 63 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +13